MED15 and nonpapillary renal cell carcinoma: To further confirm these results, we examined the expression levels of MED15 in ccRCC patients using quantitative reverse transcription-polymerase chain reaction (qRT‐PCR) (Fig. 1F), western blotting (Fig. 1G), and immunohistochemistry (IHC) (Fig. 1H).